Biofilm Formation on Intravascular Catheters and Methods of Infection Prevention

Innovations in Biomaterial Technology: Our advancements in biomaterial technology have been nothing short of groundbreaking. The results from our studies presented at the AVA Annual Scientific Meeting have shown our MIMIX hydrophilic biomaterial (HBM) to significantly reduce bacterial adhesion and thrombus accumulation. This innovation could revolutionize the way we approach vascular access, with potential to significantly lower the risks associated with central-line associated bloodstream infections (CLABSI). It's a shining example of how AVI is leading the way in medical device innovation.